Autoimmune & Inflammatory
Advancing Autoimmune Clinical Research
Autoimmune diseases affect millions worldwide, causing chronic inflammation, pain, and reduced quality of life. CenExel partners with sponsors to accelerate innovative therapies for autoimmune and inflammatory conditions through expert-driven clinical research, specialized patient recruitment, and experienced investigative sites.
Specialized Autoimmune Clinical Trial Expertise
CenExel provides comprehensive support for autoimmune and inflammatory clinical studies with experienced investigators, advanced recruitment strategies, and participant-centered trial execution. Our research teams are dedicated to improving treatment outcomes across a broad range of autoimmune disorders.
Improve Patient Outcomes
Accelerate Study Timelines
Autoimmune Conditions We Research
Our autoimmune research sites support a wide range of inflammatory and immune-mediated conditions for both adult and pediatric populations.
- Rheumatoid Arthritis
- Psoriasis
- Psoriatic Arthritis
- Lupus (SLE)
- Crohn’s Disease
- Ulcerative Colitis
- Multiple Sclerosis
- Ankylosing Spondylitis
Why Sponsors Choose CenExel for Autoimmune Research
CenExel combines scientific expertise, operational excellence, and participant-focused recruitment strategies to help sponsors deliver successful autoimmune clinical trials.
01
Expert Investigators
Our investigators bring extensive experience managing autoimmune and inflammatory conditions across multiple phases of research.
02
Diverse Patient Access
Access to broad and diverse patient populations improves enrollment speed and supports representative clinical outcomes.
03
Advanced Recruitment
Data-driven recruitment strategies help identify and engage qualified autoimmune participants efficiently.
04
High Enrollment Performance
Our sites consistently achieve strong enrollment and retention rates through personalized participant engagement.
Supported Autoimmune Trial Phases
CenExel supports early and late-phase autoimmune clinical trials — from first-in-human studies through Phase IV post-market research.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our autoimmune research network supports biologics, immunotherapies, and next-generation treatment approaches with experienced operational teams and proven trial execution.
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.






